Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Persistence of neuropsychiatric symptoms associated with SARS-CoV-2 positivity among a cohort of children and adolescents

Victor M. Castro, Faith M. Gunning, View ORCID ProfileRoy H. Perlis
doi: https://doi.org/10.1101/2021.09.28.21264259
Victor M. Castro
1Center for Quantitative Health, Massachusetts General Hospital and Department of Psychiatry, Harvard Medical School, Boston, MA
2Research Information Science and Computing, Mass General Brigham, Somerville, MA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Faith M. Gunning
3Department of Psychiatry, Weill Cornell Medicine, New York, New York; Weill Cornell Institute of Geriatric Psychiatry, New York, New York
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roy H. Perlis
1Center for Quantitative Health, Massachusetts General Hospital and Department of Psychiatry, Harvard Medical School, Boston, MA
MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Roy H. Perlis
  • For correspondence: rperlis@mgh.harvard.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Post-acute sequelae of COVID-19 are common among adults. The prevalence of such syndromes among community samples of children and adolescents remains less well characterized.

Method We identified all individuals age 5-18 across 2 New England health systems who had a positive SARS-CoV-2 PCR test between 3/12/2020 and 4/18/2021 and at least 90 days of follow-up visits documented in electronic health records. We identified neuropsychiatric symptoms in intervals prior to, and following, this testing using a previously-derived set of ICD-10 codes and natural language processing terms. Primary analysis examined sociodemographic features associated with presence of at least one incident (i.e., new-onset) neuropsychiatric symptom between 90 and 150 days after an initial positive test for COVID-19.

Results Among 5058 children (50% female, 2.9% Asian, 6.3% Black, and 63% White; 30% Hispanic; mean age was 12.4 (IQR 8.9-15.6), 366 (7.2%) exhibited at least one new-onset neuropsychiatric symptom between 90 and 150 days following initial SARS-CoV-2 test positivity. The most common incident symptoms at 90-150 days were headache (2.4%), mood and anxiety symptoms (2.4%), cognitive symptoms (2.3%), and fatigue (1.1%). In regression models, older children, girls, those with Hispanic ethnicity, those with public versus private insurance, and those with greater overall burden of medical comorbidity were more likely to exhibit subsequent symptoms.

Conclusion The prevalence of neuropsychiatric symptoms between 3- and 5-months following SARS-CoV-2 test positivity is similar to that observed in the period prior to infection. Prospective controlled studies will be needed to further refine these estimates.

Competing Interest Statement

This study was supported by the National Institute of Mental Health (R01MH120227, R01MH116270; Dr. Perlis). The sponsors did not contribute to any aspect of study design, data collection, data analysis, or data interpretation. The authors had the final responsibility for the decision to submit for publication. RHP holds equity in Psy Therapeutics and Belle-Torus Artificial Intelligence; serves on scientific advisory boards of Genomind, Psy Therapeutics, Belle-Torus Artificial Intelligence, and Takeda; and consults to RID Ventures and Burrage Capital.

Funding Statement

This study was supported by the National Institute of Mental Health (R01MH120227, R01MH116270; Dr. Perlis). The sponsors did not contribute to any aspect of study design, data collection, data analysis, or data interpretation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Human Research Committee of Mass General-Brigham granted a waiver of informed consent requirement for this research protocol under 45 CFR 46.116, as only secondary use of data generated by routine clinical care was required.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Per IRB approval, data cannot be released to outside investigators without permission.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 29, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Persistence of neuropsychiatric symptoms associated with SARS-CoV-2 positivity among a cohort of children and adolescents
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Persistence of neuropsychiatric symptoms associated with SARS-CoV-2 positivity among a cohort of children and adolescents
Victor M. Castro, Faith M. Gunning, Roy H. Perlis
medRxiv 2021.09.28.21264259; doi: https://doi.org/10.1101/2021.09.28.21264259
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Persistence of neuropsychiatric symptoms associated with SARS-CoV-2 positivity among a cohort of children and adolescents
Victor M. Castro, Faith M. Gunning, Roy H. Perlis
medRxiv 2021.09.28.21264259; doi: https://doi.org/10.1101/2021.09.28.21264259

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1744)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (649)
  • Epidemiology (10769)
  • Forensic Medicine (8)
  • Gastroenterology (582)
  • Genetic and Genomic Medicine (2927)
  • Geriatric Medicine (286)
  • Health Economics (530)
  • Health Informatics (1917)
  • Health Policy (832)
  • Health Systems and Quality Improvement (740)
  • Hematology (289)
  • HIV/AIDS (626)
  • Infectious Diseases (except HIV/AIDS) (12493)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (318)
  • Neurology (2777)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (553)
  • Occupational and Environmental Health (596)
  • Oncology (1451)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (254)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (378)
  • Pediatrics (863)
  • Pharmacology and Therapeutics (361)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2625)
  • Public and Global Health (5331)
  • Radiology and Imaging (1001)
  • Rehabilitation Medicine and Physical Therapy (592)
  • Respiratory Medicine (721)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (124)